Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07121933 · ClinicalTrials.gov registry record
Evaluation of Erchonia PPL Laser as a Pretreatment Adjunct to Enhance Standard Erchonia Red Laser for the Relief of Pain
A clinical trial, sponsored by Erchonia Corporation.
- Completed
- Registry status
- 44
- Enrollment target
NCT07121933: Completed study, sponsored by Erchonia Corporation.
NCT07121933 is a clinical trial that has completed, run by Erchonia Corporation. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07121933 has completed, sponsored by Erchonia Corporation.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This study is to see if applying pre-treatment with the Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy can help reduce nociceptive musculoskeletal pain
Primary Outcome
The Visual Analog Scale (VAS) from one day, baseline to endpoint measurement (following 13-minute treatment administration) is calculated for each subject. Individual subject success is defined as a 30% or greater change in VAS pain scores across the evaluation period. A negative (-) percent change indicates a decrease in pain level and is positive for individual subject success. A positive (+) percent change indicates an increase in pain level and is negative for individual subject success. Ov
Interventions
- DEVICE Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2026-03-28 |
What the finished NCT07121933 record still lists
NCT07121933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy is the first listed.
NCT07121933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07121933 about?
NCT07121933 is a clinical study titled "Evaluation of Erchonia PPL Laser as a Pretreatment Adjunct to Enhance Standard Erchonia Red Laser for the Relief of Pain". This study is to see if applying pre-treatment with the Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy can help reduce nociceptive musculoskeletal pain
What is the current status of trial NCT07121933?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2025-08-20. Estimated completion is 2026-03-28.
What interventions are being tested in trial NCT07121933?
The interventions under investigation include: Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy (DEVICE).
Who is sponsoring clinical trial NCT07121933?
This trial is sponsored by Erchonia Corporation, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI